Newsletter SFjRO

Publié le 30 juil. 2025 à 13:41
Article paru dans la revue « SFJRO / le mag » / SFJRO N°7

Sélection, résumés, conception et illustrations : ABOUELFATTAH Yazid
Sélection des articles : LARNAUDIE Audrey, CAMPS – MALÉA Alizée
Relecture : LARNAUDIE Audrey, CAMPS – MALÉA Alizée

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial, van der Wilk et al

Newsletter SFjRO

Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial, Brion et al

 

Newsletter SFjRO

Toxicity and Efficacy of Different Target Volume Delineations of Radiation Therapy Based on the Updated Radiation Therapy Oncology. Group/National Research Group and European Organization for Research and Treatment of Cancer Guidelines in Patients With Grade 3-4. Glioma: A Randomized Controlled Clinical Trial, Qiu et al

 

Newsletter SFjRO

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism, Mahé et al

 

Newsletter SFjRO

Toxicity in patients receiving radiotherapy for ultracentral stage non-small cell lung cancer: A secondary analysis of the LUSTRE. randomized trial, Wu et al

 

Newsletter SFjRO

Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial, Dawson et al

 

Newsletter SFjRO

Hypo-fractionated versus single-session radiosurgery to preserve hearing in patients affected by sporadic vestibular schwannoma. The ACOUNEU randomized clinical trial, Marchetti et al

 

Newsletter SFjRO

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial, Palma et al

 

Newsletter SFjRO

Publié le 1753875711000